Tag: immunotherapy

Viaskin Peanut

Private Law Firm to Investigate Claims on Behalf of Investors in...

It is unknown how this development will affect the ability of the company to eventually offer Viaskin Peanut as an FDA approved therapy.
Sublingual Tablet

ALK Starts Clinical Trial of SLIT Tablet to Treat Peanut Allergy

Sublingual Immunotherapy is administered via medications placed under the tongue.
Viaskin Patch

DBV Announces Positive Topline Results from Phase 3 Trial of Viaskin...

Viaskin Peanut demonstrated a statistically significant treatment effect with 67.0% of subjects meeting the treatment responder criteria after 12 months.
mother-and-daughter-brushing-teeth

Peanut Allergy Immunotherapy Toothpaste Makes Strides Toward Phase 2 Trial

Phase 1 study amended after two cohorts show no significant adverse events.
Moonlight Therapeutics Microneedle Patch

Study Finds Microneedle Delivery Successful in Test of Peanut Allergy Immunotherapy

Study finds five-minute weekly dose of peanut protein through the skin, delivered by a novel microneedle technology, was superior in desensitizing peanut-allergic mice compared to administering the protein through a skin patch.
Viaskin-Patch

Safety of Viaskin Peanut Patch Therapy Improved Over 3-Year Study

Reactions decreased over study duration.
Angany

New Vaccine Approach to Treating Food Allergies Steps Forward

Allergy treatment "tricks" the immune system into reacting in a different, safer manner.
Viaskin Peanut

FDA Wants More Viaskin Peanut Data Resulting in Further Approval Delays

Delays mount pushing trials of modified patch.
Moonlight Therapeutics Microneedle Patch

Company Receives $1.9 Million Grant to Advance Microneedle Patch Therapy for...

Grant will allow Moonlight Therapeutics to complete pre-clinical activities and submit and IND to the FDA.